Maravai LifeSciences Holdings Inc
F:MAR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Maravai LifeSciences Holdings Inc
F:MAR
|
US |
|
C
|
Coloplast A/S
F:CBHD
|
DK |
|
China Merchants Bank Co Ltd
F:M4BB
|
CN |
|
Impala Platinum Holdings Ltd
OTC:IMPUY
|
ZA |
|
B
|
Ba Airport Leasehold Real Estate Investment Trust
SET:BAREIT
|
TH |
|
DocMorris AG
SIX:DOCM
|
CH |
|
Xtb SA
F:9PR
|
PL |
|
Imperial Oil Ltd
TSX:IMO
|
CA |
|
S
|
Sirius XM Holdings Inc
XMUN:RDO
|
US |
|
B
|
Brinks Co
SWB:PTY
|
US |
|
Italian Exhibition Group SpA
MIL:IEG
|
IT |
|
H
|
Healthcare Trust Of America Inc
F:HT01
|
US |
|
Fresenius Medical Care AG & Co KGaA
NYSE:FMS
|
DE |
|
AxoGen Inc
F:LT3
|
US |
|
C
|
Compagnie de Saint Gobain SA
SIX:GOB
|
FR |
|
Woolworths Holdings Ltd
F:WN30
|
ZA |
Wall St Price Targets
MAR Price Targets Summary
Maravai LifeSciences Holdings Inc
According to Wall Street analysts, the average 1-year price target for MAR is 3.43 EUR with a low forecast of 2.98 EUR and a high forecast of 3.71 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MAR's stock price target?
Price Target
3.43
EUR
According to Wall Street analysts, the average 1-year price target for MAR is 3.43 EUR with a low forecast of 2.98 EUR and a high forecast of 3.71 EUR.
What is the Revenue forecast for Maravai LifeSciences Holdings Inc?
Projected CAGR
10%
Over the last 6 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 3 years is 10%.
What is the Gross Profit forecast for Maravai LifeSciences Holdings Inc?
Projected CAGR
40%
Over the last 6 years, the compound annual growth rate for Gross Profit has been -13%. The projected CAGR for the next 3 years is 40%.
